Loading
GV (Google Ventures)
Alphabet's venture arm, established in 2009. It has backed some of the best-known cancer diagnostics companies, including Foundation Medicine, Grail, Freenome and Flatiron Health, as well as cancer drug developers such as Forty Seven and Gritstone.
Overview
GV states 'EST. 2009' on its homepage and invests Alphabet's capital across AI, healthcare, dev tools and infrastructure, from seed to growth. It says it has 'partnered with 20 AI healthcare companies, including insitro and Isomorphic Labs', and operates independently of Google's business units. Its portfolio page (exits marked with an asterisk) is dense with oncology: Foundation Medicine, Flatiron Health, Grail, Freenome, Forty Seven (CD47 antibody, acquired by Gilead), Gritstone Bio, Arcus Biosciences, Accent Therapeutics, Ideaya Biosciences, IconOVir Bio, Owkin and Oxford Science Enterprises, alongside genomics platforms such as Editas and Beam.
Portfolio
5Portfolio (5)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| EpiBiologics San Mateo, CA, US | Growth stage | biotech | Non-small-cell lung cancerHead and neck squamous cell carcinoma | Series B 2026, $107M |
| Mestag Therapeutics Cambridge, GB | Growth stage | biotech | Financing 2026, $40M | |
| Nimbus Therapeutics Boston, MA, US | Growth stage | biotech | Crossover 2023, $210M | |
| Parabilis Medicines Cambridge, MA, US | Public | biotech | Desmoid tumourFamilial adenomatous polyposis-associated colorectal cancerHepatocellular carcinomaColorectal cancerProstate cancer | IPO 2026, $670M |
| Stipple Bio Cambridge, MA, US | Startup | biotech | Series A 2026, $100M |
Notes
- Headquarters city follows the task hint; GV's site does not state an address. Several of these companies (Foundation Medicine, Grail, Freenome, Flatiron Health, Gritstone, Owkin, Isomorphic Labs) are already in the graph.
Connected
9Similar pages
- CompanyJohnson & Johnson Innovation - JJDC
Shares Mestag Therapeutics, EpiBiologics and the tag corporate-venture.
- CompanyNovartis Venture Fund
Shares EpiBiologics and the tag corporate-venture.
- CompanySV Health Investors
Shares Mestag Therapeutics, Nimbus Therapeutics.
- CompanyPolaris Partners
Shares EpiBiologics, Freenome.
- CompanyRA Capital Management
Shares Stipple Bio, Parabilis Medicines.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
gv.com · 2
A source that has moved or gone is reported by the weekly link check. /audit/